Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Harrow Middlesex, United Kingdom Clinical Trials

A listing of Harrow Middlesex, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants

The purpose of the study is to evaluate the safety and tolerability of single and multiple oral doses of JNJ-64417184 administered to healthy participants and the antiviral effect of multiple oral doses of JNJ-64417184 compared to placebo in participants infected through inoculation with respiratory syncytial virus (RSV)-A Memphis 37b (Part ...

Phase

4.44 miles

Learn More »

Effect of Fibre Supplements on Gestational Diabetes

Aim: To evaluate the effect of a soluble fibre supplement in glucose metabolism in pregnant women at high risk of developing gestational diabetes. Study methodology: 12 week randomised, placebo-controlled, single-blinded study. Intervention: Women will first be categorised according to their glycaemic status into two groups: GDM and glucose tolerant women. ...

Phase N/A

6.35 miles

Learn More »

Investigating the Physiological Effects of Weight Loss on Male Fertility

Please contact study staff for a detailed description.

Phase N/A

6.36 miles

Learn More »

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

The primary objective of this prospective, multicenter, double-blind, randomized, placebo-controlled, parallel group, Phase 3 study is to determine the effect of oral lucerastat monotherapy on neuropathic pain in subjects with Fabry disease (FD) through daily collection of patient-reported outcomes with an electronic diary.

Phase

7.82 miles

Learn More »

A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities

This is a First-in-Human (FIH), 2-part, Phase 1/2, open-label, multicenter study design to evaluate the safety, tolerability, PK, pharmacodynamics, PGx, and efficacy of TAS0728. This study consists of Phase 1 and Phase 2a components in subjects with advanced solid tumors with HER2 or HER3 overexpression, amplification, or mutation who have ...

Phase

9.3 miles

Learn More »

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

This study will look at the change in participants' body weight from the start to the end of the study. The weight loss in participants taking semaglutide (a new medicine) will be compared to the weight loss of participants taking "dummy" medicine. In addition to taking the medicine, participants will ...

Phase

9.71 miles

Learn More »